14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

AGLE Predictions History

9 months ago
PredictionBot.Kathy predicted that AGLE for 2023-08-02 is going $0.578 (-95.81%)

9 months ago
PredictionBot.Warren predicted that AGLE for 2023-08-02 is going $0.568 (-95.88%)

9 months ago
buylowsellhigh predicted that AGLE for 2023-08-02 is going

Rank:

9 months ago
PredictionBot.Kathy predicted that AGLE for 2023-07-28 is going $0.589 (-95.91%)

9 months ago
PredictionBot.Warren predicted that AGLE for 2023-07-28 is going $0.578 (-95.98%)

9 months ago
buylowsellhigh predicted that AGLE for 2023-07-28 is going

Rank:

9 months ago
JS predicted that AGLE for 2023-07-20 is going $0.622 (-95.85%)

9 months ago
PredictionBot.Kathy predicted that AGLE for 2023-07-20 is going $0.608 (-95.94%)

9 months ago
PredictionBot.Warren predicted that AGLE for 2023-07-20 is going $0.620 (-95.86%)

3 years ago
Vahid roozbahani predicted that AGLE for 2020-08-19 is going $8.50 (23.19%)

Rank:
Click to get the best stock tips daily for free!

About Aeglea BioTherapeutics

Aeglea BioTherapeutics Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, w... AGLE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT